AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Wide Market Index Fund Comparison Retirement presents a concise side-by-side look at major funds, focusing on fees, diversification, and performance implications.
28,221 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Goldman Sachs forecasts a path to $100 oil as geopolitical tensions and supply discipline tighten markets. Meanwhile,...
Christina Qi, once at the helm of a high-speed trading firm, has launched Databento into the market data arena. The s...
XRP ETFs have drawn swollen inflows since November, yet the price remains soft. Analysts say a multi-billion dollar r...
Hyperliquid Strategies’ billion hype treasury trade moves into public markets, as liquidity remains untested and inve...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
SpaceX is rumored to pursue a summer IPO valued at about $1.5 trillion, a move that would reshape public market norms...
Nebius Group launches a $4 billion convertible-note round to accelerate a 1.2 GW AI data center project, backed by Nv...
NYSE has posted a listing for MSBT, a potential Morgan Stanley Bitcoin Trust. Market watchers say the bank’s first ba...
March 2026 brings a notable shift in the U.S. housing market: a broad cool-down that economists call the Great Stall....
Berkshire Hathaway reports a record cash and Treasury position, signaling Buffett’s readiness to act when markets dis...